HEALTH NEWS
Study Title:
Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers
Study Abstract
Cancer is a life-threatening disease and is the second leading cause of death around the world. The increasing threats of drug-resistant cancers indicate that there is an urgent need for the improvement or development of more effective anticancer agents. Curcumin, a phenolic compound originally derived from turmeric plant (Curcuma longa L. (Zingiberaceae family)) widely known as a spice and a coloring agent for food have been reported to possess notable anticancer activity by inhibiting the proliferation and metastasis, and enhancing cell cycle arrest or apoptosis in various cancer cells. In spite of all these benefits, the therapeutic application of curcumin in clinical medicine and its bioavailability are still limited due to its poor absorption and rapid metabolism. Structural modification of curcumin through the synthesis of curcumin-based derivatives is a potential approach to overcome the above limitations. Curcumin derivatives can overcome the disadvantages of curcumin while enhancing the overall efficacy and hindering drug resistance. This article reports a review of published curcumin derivatives and their enhanced anticancer activities.
Study Information
Molecules . 2019 Nov 30;24(23):4386. doi: 10.3390/molecules24234386.Full Study
https://pubmed.ncbi.nlm.nih.gov/31801262/Recent News
Turmeric is a Goldmine for Women’s, Men’s, and Colon Health
OptiMSM® Sulfur: Key for Body Repair, Exercise Recovery, and Hair Strength
The Essential Role of B Vitamins in Blood Sugar and Kidney Health
Keratin: The Key to Stronger, Healthier Hair
Beauty from the Inside Out: Discover Our New Hair, Skin & Nails Supplement